Skip to main content
. 2017 Feb 15;12(2):e0172131. doi: 10.1371/journal.pone.0172131

Table 3. Predicted targets of miR-19a, -20a, -185 and -374b in complement and coagulation cascade.

hsa-miRNA Predicted targets
miR-19a AT3, CD46, CD55, F5, F13, PAI-1, TF, TFPI and PLAU
miR-20a CD46 and PAI-1
miR-185 CD46, F7, F8, F11, F13 and PLAT
miR-374b CD46, CD55, F5, PAI-2 and TFPI

AT3: Anti-thrombin III. CD46: Cluster of differentiation 46. CD55: Cluster of differentiation 55. F5: Factor V. F7: Factor VII. F8: Factor VIII. F11: Factor XI. F13: Factor XIII. PAI-1: Plasminogen activator inhibitor-1. PAI-2: Plasminogen activator inhibitor-2. PLAT: tissue plasminogen activator. PLAU: urokinase-type plasminogen activator. TF: Tissue factor. TFPI: Tissue factor pathway inhibitor.